The Pancreatic Cancer Market is being transformed by cutting-edge technologies such as AI-assisted imaging, robotic-assisted surgery, liquid biopsies, and biomarker-driven diagnostics. These innovations are improving early detection, treatment accuracy, and patient monitoring. Pharmaceutical companies are increasingly developing personalized therapies targeting specific genetic mutations,...